Eagan Roger, Twigg Homer L, French Neil, Musaya Janelisa, Day Richard B, Zijlstra Eduard E, Tolmie Helen, Wyler David, Molyneux Malcolm E, Gordon Stephen B
Division of Pulmonary, Allergy, Critical Care, and Occupational Medicine, Indiana University Medical Center, Indianapolis, IN, USA.
Clin Infect Dis. 2007 Jun 15;44(12):1632-8. doi: 10.1086/518133. Epub 2007 May 10.
The incidence of pneumococcal pneumonia is greatly increased among human immunodeficiency virus (HIV)-infected subjects, compared with among non-HIV-infected subjects. Lung fluid levels of immunoglobulin G (IgG) specific for pneumococcal capsular polysaccharide are not reduced in HIV-infected subjects; therefore, we examined immunoglobulin subtypes and compared lung fluid IgG opsonic function in HIV-infected subjects with that in healthy subjects.
Bronchoalveolar lavage (BAL) fluid and serum samples were collected from 23 HIV-infected and 26 uninfected subjects. None of the subjects were receiving highly active antiretroviral therapy, and none had received pneumococcal vaccination. Pneumococcal capsule-specific IgG levels in serum and BAL fluid were measured by enzyme-linked immunosorbent assay, and IgG was concentrated from 40 mL of BAL fluid. Opsonization and opsonophagocytosis of pneumococci with serum, BAL fluid, and BAL IgG were compared between HIV-infected subjects and healthy subjects.
The effect of type 1 pneumococcal capsular polysaccharide-specific IgG in opsonizing of pneumococci was significantly less using both serum and BAL IgG from HIV-infected subjects, compared with serum and BAL IgG from healthy subjects (mean level, 8.9 fluorescence units [95% confidence interval, 8.1-9.7 fluorescence units] vs. 12.1 fluorescence units [95% confidence interval, 9.7-15.2 fluorescence units]; P=.002 for lung BAL IgG). The opsonophagocytosis of pneumococci observed using BAL IgG from HIV-infected subjects was significantly less than that observed using BAL IgG from healthy subjects (37 fluorescence units per ng of IgG [95% confidence interval, 25-53 fluorescence units per ng of IgG] vs. 127 fluorescence units per ng of IgG [95% confidence interval, 109-145 fluorescence units per ng of IgG]; P<.001).
HIV infection is associated with decreased antipneumococcal opsonic function in BAL fluid and serum.
与未感染人类免疫缺陷病毒(HIV)的受试者相比,HIV感染受试者中肺炎球菌肺炎的发病率大幅增加。HIV感染受试者中针对肺炎球菌荚膜多糖的免疫球蛋白G(IgG)的肺液水平并未降低;因此,我们检测了免疫球蛋白亚型,并比较了HIV感染受试者与健康受试者肺液IgG的调理功能。
从23名HIV感染受试者和26名未感染受试者中采集支气管肺泡灌洗(BAL)液和血清样本。所有受试者均未接受高效抗逆转录病毒治疗,且均未接种肺炎球菌疫苗。采用酶联免疫吸附测定法测量血清和BAL液中肺炎球菌荚膜特异性IgG水平,并从40 mL BAL液中浓缩IgG。比较HIV感染受试者与健康受试者血清、BAL液和BAL IgG对肺炎球菌的调理作用和调理吞噬作用。
与健康受试者的血清和BAL IgG相比,HIV感染受试者的血清和BAL IgG对1型肺炎球菌荚膜多糖特异性IgG调理肺炎球菌的作用明显较弱(平均水平,8.9荧光单位[95%置信区间,8.1 - 9.7荧光单位]对12.1荧光单位[95%置信区间,9.7 - 15.2荧光单位];肺BAL IgG的P = 0.002)。HIV感染受试者的BAL IgG观察到的肺炎球菌调理吞噬作用明显低于健康受试者的BAL IgG(每纳克IgG 37荧光单位[95%置信区间,每纳克IgG 25 - 53荧光单位]对每纳克IgG 127荧光单位[95%置信区间,每纳克IgG 109 - 145荧光单位];P < 0.001)。
HIV感染与BAL液和血清中抗肺炎球菌调理功能降低有关。